Back
Guggenheim Strategic Opportunities Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
49
GOF
Guggenheim Strategic Opportunities Fund
Last Price:
$12.13
Seasonality Move:
0.55%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$54.84
Seasonality Move:
14.46%
Sell
49
Guggenheim Strategic Opportunities Fund (GOF)
is a Sell
Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?
-
The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.07. The Score for GOF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
GOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOF Stock Price Chart
What is Guggenheim Strategic Opportunities Fund's stock price today?
-
The Guggenheim Strategic Opportunities Fund share price today is $12.07Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $54.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
GOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 34.86 | Sell |
| Chaikin Money Flow: | 931807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.94 - 12.6) | Sell |
| Bollinger Bands (100): | (12.8 - 15.16) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 45.45 | Sell |
| Chaikin Money Flow: | -1078798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.55 - 56.85) | Buy |
| Bollinger Bands (100): | (52.52 - 65.44) | Sell |
GOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.12 | Sell |
| 20-day SMA: | 12.16 | Sell |
| 50-day SMA: | 13.01 | Sell |
| 200-day SMA: | 14.43 | Sell |
| 8-day EMA: | 12.12 | Sell |
| 20-day EMA: | 12.28 | Sell |
| 50-day EMA: | 12.91 | Sell |
| 200-day EMA: | 14.17 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.72 | Sell |
| 20-day SMA: | 54.52 | Buy |
| 50-day SMA: | 59.78 | Sell |
| 200-day SMA: | 50.98 | Buy |
| 8-day EMA: | 56.04 | Sell |
| 20-day EMA: | 55.88 | Sell |
| 50-day EMA: | 56.44 | Sell |
| 200-day EMA: | 37.2 | Buy |
Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Guggenheim Strategic Opportunities Fund Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||